Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 4/2017

01-11-2017 | Original Article

The relationship between the latency period, infection markers, and oxidant and antioxidant states in women with preterm premature rupture of membranes

Authors: N. Ilhan, B. K. Aygun, H. Gungor

Published in: Irish Journal of Medical Science (1971 -) | Issue 4/2017

Login to get access

Abstract

Background

A major cause of perinatal morbidity and mortality has been reported to be preterm premature rupture of membranes (PPROM). Our objective was to evaluate oxidant–antioxidant balance, infection parameters, time interval between rupture of membranes and delivery (latency period), and the relationship among all these parameters.

Methods

Seventy-five cases with PPROM between 24 and 34 gestational weeks were included in the study. A control group of 41 women who gave birth at term were considered as the control group. The relationship among maternal plasma total oxidative stress (TOS), malondialdehyde (MDA), total antioxidant status (TAS), leukocyte counts, CRP, vitamin C and E levels, gestational week, neonatal birthweight, and latency period was evaluated.

Results

In cases with PPROM, rupture occurred at an average of 29.4 gestational weeks and premature babies were born at an average of 31.6 gestational weeks. The mortality rate of babies born to PPROM women was 18.7% (14/75) died at or following birth. In the PPROM group, TOS, MDA, and leukocyte counts were found to be significantly higher compared to the control group (p < 0.001). Besides, a significant negative correlation was detected among the latency period, TOS, CRP, and leukocyte counts (p < 0.05).

Conclusions

Appropriate treatment protocols that strengthen antioxidant defense systems and taking into consideration the signs of infection can decrease the incidence of PPROM and/or mortality rates of babies born to PPROM women.
Literature
2.
go back to reference Mercer BM (2003) Preterm premature rupture of the membranes. Obstet Gynecol 101(1):178–193PubMed Mercer BM (2003) Preterm premature rupture of the membranes. Obstet Gynecol 101(1):178–193PubMed
3.
go back to reference Parry S, Strauss JF 3rd (1998) Premature rupture of the fetal membranes. N Engl J Med 338(10):663–670CrossRefPubMed Parry S, Strauss JF 3rd (1998) Premature rupture of the fetal membranes. N Engl J Med 338(10):663–670CrossRefPubMed
4.
go back to reference Andrews WW, Goldenberg RL, Mercer B et al (2000) The Preterm Prediction Study: association of second-trimester genitourinary Chlamydia infection with subsequent spontaneous preterm birth. Am J Obstet Gynecol 183(3):662–668CrossRefPubMed Andrews WW, Goldenberg RL, Mercer B et al (2000) The Preterm Prediction Study: association of second-trimester genitourinary Chlamydia infection with subsequent spontaneous preterm birth. Am J Obstet Gynecol 183(3):662–668CrossRefPubMed
5.
go back to reference Khadem N, Mohammadzadeh A, Farhat AS et al (2012) Relationship between low birth weight neonate and maternal serum zinc concentration. Iran Red Crescent Med J 14(4):240–244PubMedPubMedCentral Khadem N, Mohammadzadeh A, Farhat AS et al (2012) Relationship between low birth weight neonate and maternal serum zinc concentration. Iran Red Crescent Med J 14(4):240–244PubMedPubMedCentral
6.
go back to reference Tejero E, Perichart O, Pfeffer F et al (2003) Collagen synthesis during pregnancy, vitamin C availability, and risk of premature rupture of fetal membranes. Int J Gynaecol Obstet 81(1):29–34CrossRefPubMed Tejero E, Perichart O, Pfeffer F et al (2003) Collagen synthesis during pregnancy, vitamin C availability, and risk of premature rupture of fetal membranes. Int J Gynaecol Obstet 81(1):29–34CrossRefPubMed
8.
go back to reference Woods JR Jr (2001) Reactive oxygen species and preterm premature rupture of membranes—a review. Placenta 22(Suppl A):S38–S44CrossRefPubMed Woods JR Jr (2001) Reactive oxygen species and preterm premature rupture of membranes—a review. Placenta 22(Suppl A):S38–S44CrossRefPubMed
9.
go back to reference Kacerovsky M, Tothova L, Menon R et al (2014) Amniotic fluid markers of oxidative stress in pregnancies complicated by preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med 27:1–10 Kacerovsky M, Tothova L, Menon R et al (2014) Amniotic fluid markers of oxidative stress in pregnancies complicated by preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med 27:1–10
11.
go back to reference Plessinger MA, Woods JR Jr, Miller RK (2000) Pretreatment of human amnion-chorion with vitamins C and E prevents hypochlorous acid-induced damage. Am J Obstet Gynecol 183(4):979–985CrossRefPubMed Plessinger MA, Woods JR Jr, Miller RK (2000) Pretreatment of human amnion-chorion with vitamins C and E prevents hypochlorous acid-induced damage. Am J Obstet Gynecol 183(4):979–985CrossRefPubMed
12.
go back to reference Siega-Riz AM, Promislow JH, Savitz DA et al (2003) Vitamin C intake and the risk of preterm delivery. Am J Obstet Gynecol 189(2):519–525CrossRefPubMed Siega-Riz AM, Promislow JH, Savitz DA et al (2003) Vitamin C intake and the risk of preterm delivery. Am J Obstet Gynecol 189(2):519–525CrossRefPubMed
13.
go back to reference Gungorduk K, Asicioglu O, Gungorduk OC et al (2014) Does vitamin C and vitamin E supplementation prolong the latency period before delivery following the preterm premature rupture of membranes? A randomized controlled study. Am J Perinatol 31(3):195–202. doi:10.1055/s-0033-1343774 PubMed Gungorduk K, Asicioglu O, Gungorduk OC et al (2014) Does vitamin C and vitamin E supplementation prolong the latency period before delivery following the preterm premature rupture of membranes? A randomized controlled study. Am J Perinatol 31(3):195–202. doi:10.​1055/​s-0033-1343774 PubMed
15.
go back to reference Shim SS, Romero R, Hong JS et al (2004) Clinical significance of intra-amniotic inflammation in patients with preterm premature rupture of membranes. Am J Obstet Gynecol 191(4):1339–1345CrossRefPubMed Shim SS, Romero R, Hong JS et al (2004) Clinical significance of intra-amniotic inflammation in patients with preterm premature rupture of membranes. Am J Obstet Gynecol 191(4):1339–1345CrossRefPubMed
17.
go back to reference Soydinc HE, Sak ME, Evliyaoglu O et al (2013) Prolidase, matrix metalloproteinases 1 and 13 activity, oxidative-antioxidative status as a marker of preterm premature rupture of membranes and chorioamnionitis in maternal vaginal washing fluids. Int J Med Sci 10(10):1344–1351. doi:10.7150/ijms.4802 CrossRefPubMedPubMedCentral Soydinc HE, Sak ME, Evliyaoglu O et al (2013) Prolidase, matrix metalloproteinases 1 and 13 activity, oxidative-antioxidative status as a marker of preterm premature rupture of membranes and chorioamnionitis in maternal vaginal washing fluids. Int J Med Sci 10(10):1344–1351. doi:10.​7150/​ijms.​4802 CrossRefPubMedPubMedCentral
19.
go back to reference Longini M, Perrone S, Vezzosi P et al (2007) Association between oxidative stress in pregnancy and preterm premature rupture of membranes. Clin Biochem 40(11):793–797CrossRefPubMed Longini M, Perrone S, Vezzosi P et al (2007) Association between oxidative stress in pregnancy and preterm premature rupture of membranes. Clin Biochem 40(11):793–797CrossRefPubMed
20.
go back to reference Stuart EL, Evans GS, Lin YS, Powers HJ (2005) Reduced collagen and ascorbic acid concentrations and increased proteolytic susceptibility with prelabor fetal membrane rupture in women. Biol Reprod 72(1):230–235CrossRefPubMed Stuart EL, Evans GS, Lin YS, Powers HJ (2005) Reduced collagen and ascorbic acid concentrations and increased proteolytic susceptibility with prelabor fetal membrane rupture in women. Biol Reprod 72(1):230–235CrossRefPubMed
21.
go back to reference Wall PD, Pressman EK, Woods JR Jr (2002) Preterm premature rupture of the membranes and antioxidants: the free radical connection. J Perinat Med 30(6):447–457CrossRefPubMed Wall PD, Pressman EK, Woods JR Jr (2002) Preterm premature rupture of the membranes and antioxidants: the free radical connection. J Perinat Med 30(6):447–457CrossRefPubMed
23.
go back to reference Hauth JC, Clifton RG, Roberts JM et al (2010) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units Network (MFMU). Vitamin C and E supplementation to prevent spontaneous preterm birth: a randomized controlled trial. Obstet Gynecol 116(3):653–658. doi:10.1097/AOG.0b013e3181ed721d CrossRefPubMedPubMedCentral Hauth JC, Clifton RG, Roberts JM et al (2010) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units Network (MFMU). Vitamin C and E supplementation to prevent spontaneous preterm birth: a randomized controlled trial. Obstet Gynecol 116(3):653–658. doi:10.​1097/​AOG.​0b013e3181ed721d​ CrossRefPubMedPubMedCentral
24.
go back to reference Osaikhuwuomwan JA, Okpere EE, Okonkwo CA et al (2011) Plasma vitamin C levels and risk of preterm prelabour rupture of membranes. Arch Gynecol Obstet 284(3):593–597CrossRefPubMed Osaikhuwuomwan JA, Okpere EE, Okonkwo CA et al (2011) Plasma vitamin C levels and risk of preterm prelabour rupture of membranes. Arch Gynecol Obstet 284(3):593–597CrossRefPubMed
25.
go back to reference Zamani M, Goodarzi MT, Lavasani NS, Khosravi A (2013) Effects of ascorbic Acid on serum level of unconjugated estriol and its relationship with preterm premature rupture of membrane: a double-blind randomized controlled clinical trial. Iran J Med Sci 38(3):227–232PubMedPubMedCentral Zamani M, Goodarzi MT, Lavasani NS, Khosravi A (2013) Effects of ascorbic Acid on serum level of unconjugated estriol and its relationship with preterm premature rupture of membrane: a double-blind randomized controlled clinical trial. Iran J Med Sci 38(3):227–232PubMedPubMedCentral
26.
go back to reference Borna S, Borna H, Daneshbodie B (2005) Vitamins C and E in the latency period in women with preterm premature rupture of membranes. Int J Gynaecol Obstet 90(1):16–20CrossRefPubMed Borna S, Borna H, Daneshbodie B (2005) Vitamins C and E in the latency period in women with preterm premature rupture of membranes. Int J Gynaecol Obstet 90(1):16–20CrossRefPubMed
28.
go back to reference Dale PO, Tanbo T, Bendvold E, Moe N (1989) Duration of the latency period in preterm premature rupture of the membranes. Maternal and neonatal consequences of expectant management. Eur J Obstet Gynecol Reprod Biol 30:257–262CrossRefPubMed Dale PO, Tanbo T, Bendvold E, Moe N (1989) Duration of the latency period in preterm premature rupture of the membranes. Maternal and neonatal consequences of expectant management. Eur J Obstet Gynecol Reprod Biol 30:257–262CrossRefPubMed
29.
30.
go back to reference Tews G, Shebl O, Ebner T et al (2004) Premature rupture of membranes with oligo- or anhydramnios before 24 weeks of gestation and the chances of fetal survival. Wien Klin Wochenschr 116:692–694CrossRefPubMed Tews G, Shebl O, Ebner T et al (2004) Premature rupture of membranes with oligo- or anhydramnios before 24 weeks of gestation and the chances of fetal survival. Wien Klin Wochenschr 116:692–694CrossRefPubMed
Metadata
Title
The relationship between the latency period, infection markers, and oxidant and antioxidant states in women with preterm premature rupture of membranes
Authors
N. Ilhan
B. K. Aygun
H. Gungor
Publication date
01-11-2017
Publisher
Springer London
Published in
Irish Journal of Medical Science (1971 -) / Issue 4/2017
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-017-1570-7

Other articles of this Issue 4/2017

Irish Journal of Medical Science (1971 -) 4/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine